학술논문

Formulation of Modified Liquid-Solid Compact for Dissolution Enhancement of Raloxifene Hydrochloride
Document Type
Periodical
Source
Pharmaceutical Technology Europe. July 2021, Vol. 33 Issue 7, p16, 5 p.
Subject
Osteoporosis -- Research
Raloxifene -- Research
Postmenopausal women -- Research
Povidone -- Research
Estrogen -- Antagonists
Business
Pharmaceuticals and cosmetics industries
Research
Language
English
ISSN
1753-7967
Abstract
Raloxifene hydrochloride (RLX), used in postmenopausal osteoporosis, is a class-ll drug as per Biopharmaceutics Classification System. The purpose of this research was to formulate modified liquisolid compacts (MLSC) of RLX [...]